Emelie Karnevi (Former)
1 – 5 of 17
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer : longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
(
- Contribution to journal › Article
- 2020
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
(
- Contribution to journal › Article
-
Mark
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
(
- Contribution to journal › Article
- 2019
-
Mark
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
(
- Contribution to journal › Article